Arsenic trioxide promotes senescence and regulates the balance of adipogenic and osteogenic differentiation in human mesenchymal stem cells

Acta Biochimica et Biophysica Sinica

Volumn 43, Issue 3, 2011, Pages 204-209

  Cheng, Huanchen ^a,b   Qiu, Lin ^b   Zhang, Hao ^b   Cheng, Mei ^b   Li, Wei ^b   Zhao, Xuefei ^b   Liu, Keyu ^b   Lei, Lei ^a   Ma, Jun ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Harbin First Hospital   (China)

Author keywords

arsenic trioxide; C EBP ; differentiation; mesenchymal stem cells; PPAR

Indexed keywords

ARSENIC TRIOXIDE; CCAAT ENHANCER BINDING PROTEIN ALPHA; CYCLIN DEPENDENT KINASE INHIBITOR 1A; ORGANOARSENIC DERIVATIVE; OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOGENESIS; AGING; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; HUMAN; MESENCHYMAL STEM CELL; METABOLISM;

ADIPOGENESIS; AGING; ARSENICALS; BONE MARROW CELLS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HUMANS; MESENCHYMAL STEM CELLS; OSTEOGENESIS; OXIDES; PPAR GAMMA;

EID: 79951876717     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmq130     Document Type: Article

References (22)

1. Tseng CH, Tai TY, Chong CK, Tseng CP, Lai MS, Lin BJ and Chiou HY, et al. Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan. Environ Health Perspect 2000, 108: 847-851.
2. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ and Corso D, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 1998, 339: 1341-1348. (Pubitemid 28509343)
3. Zhang TD, Chen GQ, Wang ZG, Wang ZY, Chen SJ and Chen Z. Arsenic trioxide, a therapeutic agent for APL. Oncogene 2001, 20: 7146-7153. (Pubitemid 33105004)
4. Kachinskas DJ, Phillips MA, Qin Q, Stokes JD and Rice RH. Arsenate perturbation of human keratinocyte differentiation. Cell Growth Differ 1994, 5: 1235-1241. (Pubitemid 24347402)
5. Trouba KJ, Wauson EM and Vorce RL. Sodium arsenite inhibits terminal differentiation of murine C3H 10T1/2 preadipocytes. Toxicol Appl Pharmacol 2000, 168: 25-35.
6. Mimeault M and Batra SK. Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies. Stem Cells 2006, 24: 2319-2345. (Pubitemid 44679695)
7. Chen Y, Shao JZ, Xiang LX, Dong XJ and Zhang GR. Mesenchymal stem cells: a promising candidate in regenerative medicine. Int J Biochem Cell Biol 2008, 40: 815-820.
8. Giordano A, Galderisi U and Marino IR. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol 2007, 211: 27-35. (Pubitemid 46363893)
9. Kaplan FS and Shore EM. Progressive osseous heteroplasia. J Bone Miner Res 2000, 15: 2084-2094.
10. Burkhardt R, Kettner G, Böhm W, Schmidmeier M, Schlag R, Frisch B and Mallmann B, et al. Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study. Bone 1987, 8: 157-164. (Pubitemid 17111858)
11. Kajkenova O, Lecka-Czernik B, Gubrij I, Hauser SP, Takahashi K, Parfitt AM and Jilka RL, et al. Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia. J Bone Miner Res 1997, 12: 1772-1779. (Pubitemid 27500188)
12. Herbig U, Jobling WA, Chen BP, Chen DJ and Sedivy JM. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell 2004, 14: 501-513. (Pubitemid 38648803)
13. Walker AM, Stevens JJ, Ndebele K and Tchounwou PB. Arsenic trioxide modulates DNA synthesis and apoptosis in lung carcinoma cells. Int J Environ Res Public Health 2010, 7: 1996-2007.
14. Lemarie A, Morzadec C, Mérino D, Micheau O, Fardel O and Vernhet L. Arsenic trioxide induces apoptosis of human monocytes during macrophagic differentiation through nuclear factor-kappaB-related survival pathway down-regulation. J Pharmacol Exp Ther 2006, 316: 304-314. (Pubitemid 41832610)
15. Wang ZX, Jiang CS, Liu L, Wang XH, Jin HJ, Wu Q and Chen Q. The role of Akt on arsenic trioxide suppression of 3T3-L1 preadipocyte differentiation. Cell Res 2005, 15: 379-386. (Pubitemid 41653932)
16. Lecka-Czernik B, Moerman EJ, Grant DF, Lehmann JM, Manolagas SC and Jilka RL. Divergent effects of selective peroxisome proliferator-activated receptorgamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 2002, 143: 2376-2384. (Pubitemid 34521584)
17. Tornvig L, Mosekilde LI, Justesen J, Falk E and Kassem M. Troglitazone treatment increases bone marrow adipose tissue volume but does not affect trabecular bone volume in mice. Calcif Tissue Int 2001, 69: 46-50. (Pubitemid 32702265)
18. Fux C, Mitta B, Kramer BP and Fussenegger M. Dualregulated expression of C/EBP-alpha and BMP-2 enables differential differentiation of C2C12 cells into adipocytes and osteoblasts. Nucleic Acids Res 2004, 32: e1.
19. Kang S, Bennett CN, Gerin I, Rapp LA, Hankenson KD and Macdougald OA. Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma. J Biol Chem 2007, 282: 14515-14524. (Pubitemid 47100486)
20. Fan Q, Tang T, Zhang X and Dai K. The role of CCAAT/enhancer binding protein (C/EBP)-alpha in osteogenesis of C3H10T1/2 cells induced by BMP-2. J Cell Mol Med 2009, 13: 2489-2505.
21. Takada I, Kouzmenko AP and Kato S. PPAR-gamma signaling crosstalk in mesenchymal stem cells. PPAR Res 2010, [Epub in pubmed].
22. Jorgensen C. Mesenchymal stem cells in arthritis: role of bone marrow microenvironment. Arthritis Res Ther 2010, 12: 135.